Dr. Jane
September 23, 2022
Recent research has confirmed the mechanism of effective treatment of gout in Korean medicine. Gout is a common and complex form of arthritis. Known as “the disease of kings,” it is one of the oldest joint diseases known to mankind. Ancient Westerners believed that taste was a “devil’s bite,” while modern medical research has found that the disease is caused …
BANGKOK, Thailand, Aug 24, 2022 /PRNewswire/ — The Faculty of Veterinary Science, Chulalongkorn University has researched and replicated “Hydroxy-xanthones”, the vital extracts rich in antioxidants found in mangosteen peels that kill germs and halt infections in the intestinal mucosa. It hopes to expand to include health products for humans and animals in the future. Not only is “Mangosteen“, the queen …
BANGKOK, Thailand, Aug 24, 2022 /PRNewswire/ — The Faculty of Veterinary Science, Chulalongkorn University has researched and replicated “Hydroxy-xanthones”, the vital extracts rich in antioxidants found in mangosteen peels that kill germs and halt infections in the intestinal mucosa. It hopes to expand to include health products for humans and animals in the future. Not only is “Mangosteen“, the queen …
market aims to assist stakeholders in gaining a competitive edge by revealing the top growth avenues during 2022-2026. The study leverages historical data as well as the latest industry-validated statistics with respect to the primary growth catalysts, opportunities, and restraints to evaluate the annual growth rate of the market and its sub-markets over the analysis timeframe. The Veterinary Orthopedic Treatment …
The Faculty of Veterinary Science, Chulalongkorn University has researched and replicated “hydroxy-xanthones”, the vital extracts rich in antioxidants found in mangosteen peels that kill germs and halt infections in the intestinal mucosa. It hopes to expand to include health products for humans and animals in the future. Not only is “Mangosteen,” the queen of Thai fruits, a delicious and healthy …
July 7, 2022 — Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced the publication of preclinical research in the July 6 issue of Science Translational Medicine. The article, titled “Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse …
the Veterinary Treatment Ozone Therapy Units report is an in-depth examination of the global Veterinary Treatment Ozone Therapy Units’s general consumption structure, development trends, sales techniques, and top nations’ sales. The research looks at well-known providers in the global Veterinary Treatment Ozone Therapy Units industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Veterinary Treatment Ozone …
Research from the University of Michigan Rogel Cancer Center could provide a new approach to treating an aggressive form of breast cancer. A study led by Duxin Sun, Ph.D. found that targeting the immune microenvironment in lymph nodes and tumors simultaneously led to long-term tumor remission in mice models of metastatic triple negative breast cancer. Further, using nanoparticles to deliver …
NEW YORK, May 5, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-designed molecules for the treatment of methylthioadenosine phosphorylase (MTAP)-deleted cancers. The PCC is part of Insilico’s growing portfolio of synthetic lethality assets in development. …
NEW YORK, May 6, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-designed molecules for the treatment of methylthioadenosine phosphorylase (MTAP)-deleted cancers. The MAT2A program is part of Insilico’s growing portfolio of synthetic lethality assets in …
